Warhammer 40K: Official trailer for Darktide’s free Nightmares and Visions update. Here are the details of the update.
Developed and published by Fatshark Warhammer 40k: Darktide“Nightmarares and Visions”, which meets players on March 25, draws attention with its free update. The game, which was first released on 30 November 2022, was available to PC users via PlayStation 5, Xbox Series and Steam. The new update adds exciting innovations and content to the game.
Warhammer 40K: Darktide Nightmarares and Visions update
The published trailer reveals the innovations brought by the “Nightmares and Visions” update. With the update, improvements were made in chaos modifications such as Enraging Elites, The Encroaching Garden, Rampaging Enemies and Heinous Rituals. In addition, a new wave -based activity Mortis Trials is offered to players. Another important innovation of the update is the recovery of the talent tree of the OGRYN class. This change gives the class more options and strength.
Mortis Trials stands out as one of the main features of the update. In this mode, players encounter a total of twelve different enemy waves, each divided into four groups, each of three waves. While each wave becomes more challenging than the previous one, as players progress, they can choose less than five different categories called “Indulgences .. In the third waves, stronger bonuses are earned.
With the update, a limited -time event, A day at Theater, started. In this event, players can earn progress points by completing four consecutive waves. In this event, which can be collected in total, awards are distributed such as ORDO DOockets, Plasteel and Diamantine. In addition, players who complete the event have the opportunity to win a special cosmetic insignia.
With the new update, Warhammer 40K: Dartede aims to offer players a more comprehensive experience. In particular, innovative game modes and class updates, such as Mortis Traals, enrich the dynamics of the game. The update is currently downloaded free of charge on all platforms.